ASTH

$ASTH chatter on StockTwits

• 
  Thecontracap@thecontracapBullish9h

  $ASTH nice pullback to enter or add. Above 100ma again, just consolidating a big move. <8x 27 ebitda, 8-9% fcf yield, growing EBITDA and fcf 15-20%/yr with no limit on white space. In 2021 these exact companies traded for 5-10x REVENUE. Now it’s <1x after enduring a horrible cycle in which the pretenders all went to 0. $ASTH has been the best operator throughout, growing every year, and is just at the beginning of a multi-year revaluation. @healthcareguru

  View on StockTwits ↗
• 
  Stocktwits Earnings@StocktwitsEarningsAug 6

  $ASTH Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.40 up 110.53% YoY • Reported revenue of $972.52M up 48.52% YoY • Astrana Health provides guidance for the three months ending September 30, 2026, with total revenue of $1,000M to $1,030M and Adjusted EBITDA of $72.5M to $77.5M for the period.

  View on StockTwits ↗
• 
  that guy@nhruchBullishAug 5

  $ASTH extremely undervalued growing at 40-50% yoy, solid investment to get in before the crowd. Healthcare services is only going to grow with an aging population. Earnings is tomorrow.

  View on StockTwits ↗
• 
  fat tony@awesome_tradesJul 27

  $ASTH 👀

  View on StockTwits ↗
• 
  Donald Osullivan@FibonacciTrader_Jul 13

  Healthcare is quietly building leadership. While much of the market is focused on AI and semis, several healthcare growth names continue to show strong Stage 2 uptrend characteristics backed by improving price action and solid fundamentals. My radar includes: $OSCR $HNGE $ASTH $HIMS These stocks continue to print higher highs, defend key moving averages, and attract institutional interest. If this sector rotation continues, healthcare could become one of the market's next leadership groups. Don't wait until everyone is talking about them-watch where the money is flowing before the headlines catch up.

  View on StockTwits ↗
• 
  Jodie Christy@JodieChristyJul 12

  Are growth mid-caps ready to melt up? $ASTH, $LMND, $BB, and$HNGE are showing textbook pattern synchronization! Most are either carving clean cup-and-handle formations or snapping out of IPO bases into brand new Stage 2 uptrends. Which one is your top pick? Real-time charts show momentum leader $LMND consolidating at $70.51 as smart money rotates into high-alpha mid-caps. Technically, these structural bases are winding tight on contracting volume. Avoid chasing the local spikes. Strategy is to scale into long tracking positions as these tickers test their daily 20-EMA floors, placing a strict risk stop right below the handle pivots to ride the structural breakout.

  View on StockTwits ↗
• 
  Thecontracap@thecontracapBullishJul 2

  @etalexan $ASTH I think $80 is a fair 6-9 month target. I’m in for long term and $150+ https://stocktwits.com/thecontracap/message/657551319

  View on StockTwits ↗
• 
  Thecontracap@thecontracapBullishJul 2

  $ASTH this is a $2BN+ mkt cap, been public for several years, has 500 watchers with basically no growth. It’s on nobody’s radar… still

  View on StockTwits ↗
• 
  Thecontracap@thecontracapBullishJul 1

  $ASTH

  View on StockTwits ↗
• 
  fat tony@awesome_tradesJul 1

  $ASTH beauty

  View on StockTwits ↗
• 
  Mr. Layne@LaynesterBullishJul 1

  $WLY $STOK $FDS $ASTH $QXO [CAH] SCANNER 'BOTTOM UP' BIG BUYS TODAY. Bears, Sell Calls, Buy Puts please document your BEAR CASE. MASSIVE PORTFOLIO BOTTOM UP SCANNER BUYS today. All (any) national Patriot un predjudice Men secure your FAMILY, HOME, TOWN, STATE, BORDER and all FUTURE ELECTIONS. Please join us world slaves and defeit the MKULTRA/MIC global elite. JOIN US world national patriotic non predjudice men and women and make a buy let's stick together...always and forever...Remember. All for one! and One for all! Lets Roll! Set a stop. Good to all us pimped out world slaves. 100%--->🦬

  View on StockTwits ↗
• 
  Nicholas@JFDIBullishJul 1

  $ASTH good lookin run

  View on StockTwits ↗
• 
  Thecontracap@thecontracapJun 29

  @ProWesTrader @PhishTourFunds I owned agl from 25, sold second half at $111. I have no idea how it trades from here but for context, $ASTH does the same thing with better results and trades at $2.75bn EV vs expected 315mm ebitda in 27. This is my biggest position. $AGL trades at $1.8bn EV vs consensus 60mm in ebitda next year. That number is low and will need to come up, so maybe that keeps pushing the price higher. But you can see agl would need to do 200mm+ ebitda in 27 to justify its current price. That seems like a very tall order to me.

  View on StockTwits ↗
• 
  Thecontracap@thecontracapBullishJun 26

  $ASTH Marry that with technicals and breakout underway, think we could get a chunk more soon

  View on StockTwits ↗
• 
  Thecontracap@thecontracapBullishJun 26

  $ASTH here’s math. 350mm 27 ebitda 14x ($INNV trades for this valuation; max health acquired by $HUM a few months ago for this valuation) 4.9bn -500mm net debt $4.4bn /55mm shares $80/sh target price This isn’t a stretch and this isn’t a meme stock. This is a real cash flowing biz with years of 15-20% growth runway.

  View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.